HEC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

HEC Trademark

Serial Number: 79227076 • Registration: 5736027

HEC is a trademark filed by YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. on November 27, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2 trademarks)

No. 38, Binjiang Road
Yichang,Hubei Province 443300 , CN

Entity Type: 99

Trademark Details

Filing Date

November 27, 2017

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Goods & Services

Medicines for human purposes for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders, cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; Medicines for human purposes, namely, anti-infectives and antivirals; Pharmaceutical preparations for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Pharmaceutical preparations, namely, anti-infectives and antivirals; Pharmaceutical preparations for the treatment of cough, cold and flu symptoms; adjuvants for medical purposes; Bulk drug in the nature of a pharmaceutical preparation for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Bulk drug in the nature of a pharmaceutical preparation, namely, anti-infectives and antivirals; Bulk drug in the nature of a pharmaceutical preparation for the treatment of hypertension, alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; Chinese patent medicines, for use in the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Chinese patent medicines, namely, anti-infectives and antivirals; Chinese patent medicines, for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; Biochemical medicines for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Biochemical medicines, namely, anti-infectives and antivirals; Biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; Medicinal infusions for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Medicinal infusions, namely, anti-infectives and antivirals; Medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, obesity, obesity associated with type 2 diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; diagnostic preparations for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; contact lens cleaning preparations; Nutritive substances for microorganisms for medical purposes; disinfectants; food for babies; infant milk powder; depuratives for the body; Veterinary preparations for horses, dogs, and cats for the prevention and treatment of pain, illness, and fatigue; Medicine health bag being medicinal herbs for general health and well-being contained in a small bag; Decoctions for pharmaceutical purposes for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Decoctions for pharmaceutical purposes, namely, anti-infectives and antivirals; Decoctions for pharmaceutical purposes for treatment of immune disorders; Drugs for medical purposes, namely, for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, ocular, reproductive, circulatory, digestive, ear, blood, psychiatric, behavioral, nervous, and immune system related diseases and disorders; Drugs for medical purposes, namely, anti-infectives and antivirals; Medical hemostatic paste; medicinal herbs; Transdermal patches for use in the temporary relief of headache and muscle pain; medicinal tea; Allergy capsules; soporifics; Biological preparations for medical purposes, namely, for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Biological preparations for medical purposes, namely, anti-infectives and antivirals; medical preparations for slimming purposes; medicinal wine; poultices; Medicine cases, portable, filled, namely, first aid kits; Medicinal oil; Liquid medicines for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Liquid medicines, namely, anti-infectives and antivirals; Liquid medicines for treating colds; Medicines for veterinary purposes for treating and preventing infections caused by bacteria or parasites in companion and food producing animals; surgical dressings; solutions for contact lenses

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 21, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 21, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 15, 2025 APRE
TEAS SECTION 71 RECEIVED
Apr 21, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 16, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 16, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2019 REAP
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTICE OF PUBLICATION
Jan 23, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2018 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 17, 2018 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2018 CRFA
ASSIGNED TO LIE
Dec 13, 2018 ALIE
NOTICE OF REVIVAL - MAILED
Dec 11, 2018 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2018 TROA
PETITION TO REVIVE-GRANTED
Dec 10, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 10, 2018 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 11, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 11, 2018 ABN2
REFUSAL PROCESSED BY IB
Mar 30, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 10, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 9, 2018 CNRT
ASSIGNED TO EXAMINER
Mar 8, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 3, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2018 REPR